The Lifespan/Tufts/Brown CFAR was established in 1998 as a collaboration between Brown University and Tufts University and their affiliated hospitals. Since the Initial CFAR award in 1998, we have successfully competed for two renewals, and met our stated benchmarks and milestones throughout the 12 years since the Initial award. We have revised our goals as the epidemic and its treatment have evolved, and steadily increased the interdisciplinary research essential to further progress in this area. This CFAR serves as the basis for extensive collaborative, interdisciplinary research among the CFAR members, and has served as the leading force in developing and supporting relevant new initiatives. This application emphasizes the return on investment of funding cross-disciplinary HIV research throughout Brown and Tufts Universities, their affiliated hospitals, and partner institutions in the developing world. In accordance with directives in the NIH CFAR PAR, we have developed a multidisciplinary environment that supports basic, clinical, epidemiologic, behavioral and translational research in the detection, prevention, and treatment of HIV infection and AIDS. This application emphasizes our progress toward this mission over the past four years, and its proposed activities over the next five years. If this application proves to be successful. Looking ahead, we Intend to further emphasize multi-institutional, cross-disciplinary studies related to HIV/AIDS both in New England and In Sub-Saharan Africa and Asia, with continuing support for our established CFAR Scientific Programs In International HIV/AIDS and in Prisoner Health and Human Rights for cross-disciplinary work In our Scientific Working Groups related to neurocognitive aspects of HIV and its treatment, cardiovascular and metabolic consequences of HIV and antiretroviral therapy In our aging population of persons living with HIV, and further multidisciplinary studies of the consequences of alcohol and other substances of abuse on HIV acquisition and response to treatment.

Public Health Relevance

Despite advances In HIV/AIDS treatment and prevention, the disease continues to ravage many lives. Our CFARs ultimate goal is to Improve the lives of people living with HIV and prevent new Infections by serving as a basis for extensive collaborative, multi and Interdisciplinary research. The development of junior investigators within the field is crucial to stemming this epidemic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042853-16
Application #
8463897
Study Section
Special Emphasis Panel (ZAI1-RRS-A (J1))
Program Officer
Namkung, Ann S
Project Start
1998-09-01
Project End
2017-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
16
Fiscal Year
2013
Total Cost
$1,941,670
Indirect Cost
$444,346
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Peterson, James; Cota, Michelle; Gray, Holly et al. (2015) Technology use in linking criminal justice reentrants to HIV care in the community: a qualitative formative research study. J Health Commun 20:245-51
Livingston, Nicholas A; Oost, Kathryn M; Heck, Nicholas C et al. (2015) The role of personality in predicting drug and alcohol use among sexual minorities. Psychol Addict Behav 29:414-9
Genberg, Becky L; Lee, Yoojin; Rogers, William H et al. (2015) Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time. AIDS Behav 19:85-92
Larney, Sarah; Mahowald, Madeline K; Scharff, Nicholas et al. (2014) Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. Am J Public Health 104:e69-74
Merchant, Roland C; Baird, Janette R; Liu, Tao et al. (2014) Brief intervention to increase emergency department uptake of combined rapid human immunodeficiency virus and hepatitis C screening among a drug misusing population. Acad Emerg Med 21:752-67
Flentje, Annesa; Heck, Nicholas C; Sorensen, James L (2014) Characteristics of transgender individuals entering substance abuse treatment. Addict Behav 39:969-75
Beckwith, Curt G; Larney, Sarah; Flanigan, Timothy P (2014) Editorial commentary: Hepatitis C virus testing and drug use in north america; is there more than meets the eye? Clin Infect Dis 58:762-4
Jonas, Anna; Sumbi, Victor; Mwinga, Samson et al. (2014) HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance. PLoS One 9:e100539
Conrad, Selby M; Tolou-Shams, Marina; Rizzo, Christie J et al. (2014) Gender differences in recidivism rates for juvenile justice youth: the impact of sexual abuse. Law Hum Behav 38:305-14
Dourado, InĂªs; MacCarthy, Sarah; Lima, Carlos et al. (2014) What's pregnancy got to do with it? Late presentation to HIV/AIDS services in Northeastern Brazil. AIDS Care 26:1514-20

Showing the most recent 10 out of 369 publications